×

RNS Number : 5911R

Sativa Group PLC

30 October 2019

 

Press Release

30 October 2019

Sativa Group Plc

 

("Sativa" or "the Company" or "the Group") 

 

Access gained to retail-majors through distribution agreement with

SHS Sales & Marketing (GB) Limited 

 

Brand name change of George Botanicals to Goodbody Botanicals 

 

Sativa Group Plc [NEX: SATI], the UK's leading quoted CBD wellness and medicinal cannabis Group, is pleased to announce that its wholly owned subsidiary, George Botanicals, has entered into a brand partnership agreement with SHS Sales & Marketing (GB) Limited ("SHS Sales & Marketing").  SHS will distribute a range of "Goodbody Botanical" branded products to UK high street grocery, pharmacy and specialist customers retailers.  

 

SHS Sales & Marketing distributes over 100 blue chip Fast-Moving Consumer Good brands in the UK and Republic of Ireland including Mars, Colgate, Lemsip and Nurofen.  SHS Sales & Marketing enjoys a market penetration to over 90% of UK households by distributing high quality products to the major high street retailers and leading convenience chains such as Sainsbury's, ASDA, Tesco, and Waitrose, as well as to pharmacies and health and wellness stores such as Holland & Barrett. 

 

As part of the distribution agreement, SHS Sales & Marketing will market the Goodbody Botanicals range on an exclusive basis to its customer base, advising on product mix along with providing promotional and communications support.  Logistics and invoicing are also included within the contract. 

 

In tandem with this significant brand partnering agreement, George Botanicals is re-branding its highly successful George Botanicals product range to "Goodbody Botanicals".  In this process the Goodbody Botanicals branding and packaging has been significantly upgraded, providing additional product information for customers.  All products are tested and certified by Phytovista laboratories and are THC free.  

 

Henry Lees-Buckley, Chief Executive of Sativa, said: "We are thrilled to be partnering with the highly regarded and successful team at SHS.  The combination of their sales, marketing and logistics support, coupled with our high quality Goodbody products, make a compelling value proposition for major high street retailers".

 

John Heynen, Managing Director of SHS Sales & Marketing GB said: " The growing demand for CBD wellness products in the UK provides us with an opportunity to further extend our offer to our customers and shoppers, and it is critical we work with the best partner to realise this.  All Goodbody Botanical products are rigorously tested to ensure that they bring high quality items to the marketplace. This attention to product development, quality and testing will provide our customers the sales opportunity and security they need".

 

For further information please contact: 

 

Henry Lees-Buckley  Chief Executive Officer Sativa Group Plc  +44 (0) 20 7971 1255   [email protected]   www.sativagroup.co.uk	Joseph Colliver Chief Financial Officer Sativa Group Plc  +44 (0) 20 7971 1255   [email protected]    www.sativagroup.co.uk
NEX Exchange Corporate Adviser   Corporate Finance    Stephen Keys / Max Gould  Cenkos Securities plc  +44 (0) 20 7397 8900
Equity Sales    Julian Morse Cenkos Securities +44 (0) 20 7397 8900
Financial PR and IR   Abchurch Communications Julian Bosdet +44 (0)207 4594 4070   +44 (0) 7771 663 886	[email protected] www.abchurch-group.com

 

Notes to Editors. 

Sativa Group Plc is the UK's leading quoted CBD wellness and medicinal cannabis group with five operating subsidiaries. 

Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers.  Goodbody Wellness is a high-street retail brand with dedicated CBD wellness stores providing a premium shopping experience to consumers.  Tessellate Collective is a direct-selling network marketing platform servicing consumers at home.  Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. 

 

Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfil its partnership agreement with King's College London to research the impact of cannabinoids on inflammation and respiratory conditions.  

 

 – Ends –

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAQBLBXKBFXFBB

Close

×

RNS Number : 3928R

Integumen PLC

29 October 2019

 

AIM share code: SKIN

29 October 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

 

Integumen launches independent Rinodrive AI open-source eco-system

 

Labskin AI demonstrates value of the Rinodrive data driven platform

 

Integumen is pleased to announce the launch of Rinodrive (www.rinodrive.com) as an independent Artificial Intelligent (AI) platform for collaboration and joint venture partners as an open-source cloud-based eco-system. The stand-alone platform is currently being rolled out with existing healthcare clients, a growing list of higher educational establishments, being tested in government departments, in a reputable UK bank and an international financial advisory firm.

 

Since 2016, Rinocloud, a wholly-owned subsidiary of Integumen, has developed Rinodrive as a data aggregation, refining and AI analysis open-source eco-system, designed to provide third-party service providers with the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

 

Gerard Brandon CEO of Integumen commented:

 

"Following the transformational change with the Integumen business model achieved in just a few months by adding AI to Labskin, we are now delighted to be able to offer the same benefits across multiple industries.  Rinodrive will act as an independent AI platform which will allow the management of Integumen to remain focused on their core Labskin AI business while deriving revenues from clients across healthcare services, third-level education, government departments and the financial sector.

 

"In the three years prior to the Rinocloud acquisition in May 2019, Rinodrive had been developed to deal with the explosive growth of data across multiple industries.  We have seen it successfully work with genetic data at Labskin and also at various scientific data at research institutes such as the University College Cork, Cambridge University and the Centre for Advanced Photonics & Process Analysis at the Cork Institute of Technology.  Rinodrive AI is now ready to help our clients and partners advance their work beyond Labskin and add a further revenue sharing source of income as we head into 2020."

 

Explosive data growth

 

It is estimated that the doubling time of medical knowledge in 1950 was 50 years and in 2010, the amount of healthcare data collected was said to be doubling every three and a half years. It is projected that by 2020 this will be every 73 days[i]. The International Data Corporation predicts a healthcare data compound annual growth rate of 36 % up to 2025 – driven by analytics, imaging and real-time data for decision support – exceeding manufacturing (30 %), finance (26 %) and media (25 %)[ii].

 

In order to ensure staff retention while at the same time improve quality of care, it is imperative that healthcare providers increase efficiency to reduce costs, waste, duplication and the length of the care to maintain patient satisfaction. Data is the key driver.

 

Connecting existing systems with open platforms, and specialists with patients, while employing AI to analyse the data and generate actionable insights is key to the increase demands on any modern-day healthcare eco-system.

 

Unexploited data

 

Rinodrive is a robust platform with state-of-the-art open-source cloud infrastructure.  Many Labskin clients already share their clinical trial results through the LabskinAI portal through secure, military grade encrypted access.

 

The business opportunity for Rinodrive will be achieved through partnership, joint venture and revenue sharing collaboration.  Consultant companies managing data aggregation and migration to the cloud can create value for the client from the use of Rinodrive AI tools on their client data. Likewise, recruitment companies supplying IT personnel in a highly competitive market for low-margin single fee income can transform their business model by targeting high margin clients contracting personnel to compete on equal terms with the likes of Accenture, McKinsey and other consultancy firms.

 

 

Integumen plc	Gerard Brandon, CEO	+44 (0) 7340 055 648
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Vassil Kirtchev	+44 (0) 113 370 8974
Turner Pope Investments (TPI) Limited (Broker)	Andy Thacker/Zoe Alexander	+44 (0) 20 3657 0050

 

About Integumen:

Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with three business units: 

 

·     Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services.  Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

·     Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

·     Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.

·     Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories. 

 

 

---

[i] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116346/

[ii] https://healthitanalytics.com/news/big-data-to-see-explosive-growth-challenging-healthcare-organizations

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCFEWFUAFUSEIS

Close

×

RNS Number : 5567Q

Cadence Minerals PLC

21 October 2019

 

Cadence Minerals Plc

 

("Cadence Minerals", "Cadence" or "the Company")

 

Hastings Technology Metals (ASX:HAS) – DRA Pacific Awarded EPCM Contract Yangibana Processing Plant.

 

Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to announce Hastings Technology Metals (ASX:HAS) ("Hastings"), Cadence's joint venture partner at the Yangibana Rare Earth Project in the Gascoyne region of Western Australia ("Yangibana Project"), has announced that it has awarded the Engineering, Procurement, Construction and Management (EPCM) contract for its rare earths processing plant and the associated infrastructure for the Yangibana process plant in the Gascoyne Region of Western Australia to DRA Pacific Pty Ltd ("DRA Pacific"), a diversified global engineering, project delivery and operations management. The appointment of DRA Pacific as the EPCM contractor for the Yangibana Project was preceded by a series of value engineering studies and the Front-End-Engineering-Design ("FEED") completed by DRA Pacific during 2018 and 2019.  DRA Pacific's EPCM contract will cover all aspects of the design and construction of the processing facility and associated non-process infrastructure capable of producing 15,000 tonnes of Mixed Rare Earths Carbonate (MREC) per year.

Cadence Minerals Yangibana Holding:

Cadence owns 30% of the Yangibana North, Gossan, Hook, Kanes Gossan, Lions Ear and Bald Hill North Rare Earth Deposit, which form part of the Yangibana Rare Earth Deposit. Probable Ore Reserves of some 2.1 million tonnes at 1.66% total rare earth elements are contained within 30% owned joint venture tenements. Further details of these reserves and pre-feasibility study can be found at: http://irservices.netbuilder.com/ir/cadence/newsArticle.php?ST=REM&id=2688632.

Highlights:

·      DRA Pacific Pty Ltd awarded the Engineering, Procurement and Contract Management (EPCM) Contract for the Yangibana Rare Earths Processing Plant.

·      The scope of works under the DRA Pacific Pty Ltd EPCM agreement has an estimated capital value of circa A$350m.

·      DRA Pacific's parent DRA Global Ltd have extensive experience in designing and building mineral processing facilities worldwide and their personnel have previously delivered rare earth plants in Western Australia.

·      The key component of the contract terms is the comprehensive performance guarantee linked to ore throughput for the entire process flow sheet.

The EPCM contract is the single largest dollar value contract associated with the Yangibana Project.  It is also a fundamental requirement of Hastings' debt providers and hence is pivotal to the project financing process. Works directed under the EPCM Contract have an estimated value of approximately A$350M.

The key component of the contract terms is the comprehensive performance guarantee linked to ore throughput for the entire process flow sheet.

The appointment of DRA Pacific as the EPCM contractor for Hastings represents another critical milestone for the Project, reinforcing that Yangibana is execution ready.

Choosing DRA Pacific was the logical choice given the already close working relationship built up over the last 15 months, and the experience in rare earths processing plant design that DRA Pacific bring to the table.

The full release can be found at: https://www.asx.com.au/asxpdf/20191021/pdf/449nzf57qlq659.pdf

Hastings Executive Chairman Charles Lew said: "We are pleased to have DRA involved in the construction of the Yangibana processing plant. Their knowledge and experience in developing successful minerals processing projects makes them the ideal candidate to manage the construction of our project. The award of the EPCM contract moves the Yangibana Rare Earths Project firmly into development phase to commence project execution and progress to production of our mixed rare earth carbonate by 2022."

Cadence CEO Kiran Morzaria commented: "The appointment of DRA Pacific represents a key step for Yangibana. Not only is it key to the project funding going forward, the EPCM contract terms include a comprehensive performance guarantee linked to ore throughput. Today's announcement provides further validation for our investment strategy into the Yangibana joint venture with Hastings."

– Ends –

For further information:

Cadence Minerals plc	+44 (0) 207 440 0647
Andrew Suckling
Kiran Morzaria
WH Ireland Limited (NOMAD & Broker)	+44 (0) 207 220 1666
James Joyce
James Sinclair-Ford
Novum Securities Limited (Joint Broker)	+44 (0) 207 399 9400
Jon Belliss

 

 

Qualified Person

Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information contained in this announcement. Kiran holds a Bachelor of Engineering (Industrial Geology) from the Camborne School of Mines and an MBA (Finance) from CASS Business School.

 

Forward-Looking Statements:

Certain statements in this announcement are or may be deemed to be forward-looking statements. Forward-looking statements are identified by their use of terms and phrases such as ''believe'' ''could'' "should" ''envisage'' ''estimate'' ''intend'' ''may'' ''plan'' ''will'' or the negative of those variations or comparable expressions including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth results of operations performance future capital and other expenditures (including the amount. nature and sources of funding thereof) competitive advantages business prospects and opportunities. Such forward-looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.  Many factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions competition environmental and other regulatory changes actions by governmental authorities the availability of capital markets reliance on key personnel uninsured and underinsured losses and other factors many of which are beyond the control of the Company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions. The Company cannot assure investors that actual results will be consistent with such forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTPGGUUUUPBGUG

Close

×

Neville Registrars is delighted to welcome Ritorno PLC as the newest addition to its list of client companies.

 

Close

×

RNS Number : 3586P

Osirium Technologies PLC

10 October 2019

 

 

 

RNS Reach

10 October 2019

 

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

New customer and upsell contract wins across multiple sectors

 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a series of contract wins with an international banking group, a leading drinks manufacturer, and a provider of services to the pharmaceutical and biotech sectors.

 

The total licenses cover 100s of devices, with contract terms of between 12 and 36 months, with Osirium delivering its PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules. 

 

For the banking group the PxM platform has been selected to secure access to web interfaces, network devices and servers, and to control access to privileged accounts by a number of the customer's key external vendors. In addition to core privileged access management functions, the customer has selected Osirium's award-winning Task Automation capabilities to enable its Helpdesk team achieve significant time savings and enhanced security by automating processes in its day to day operations.

 

The contract with the drinks manufacturer represents an expansion in less than 12 months from an original package comprising consultancy services and the PxM Express offering. The PxM platform is being used to support manaufacturing lines in drinks production, as well as controlling approval flows for time-limited access to privileged accounts, such as for third parties.

 

For the provider of services to the pharmaceutical and biotech sectors, the PxM platform is being used by the customer to minimise the risk of security breaches by delivering rigorous control and visibility of access to privileged accounts by internal users. 

 

David Guyatt, Chief Executive Officer, commented: "These contract wins underline our increasing sales momentum and clearly show successful elements of our strategy. The contract with this prestigious drinks provider is yet another illustration of our 'land and expand' strategy, with a new customer seeing the immediate benefit of Osirium and deciding – in less than twelve months – to add to its initial deployment.

 

"Complementing this is in each of these three wins is the simplicity of deploying Osirium, backed up the expertise of our support, consultancy and sales teams. These are enabling us to not only shorten sales cycles, but also win against competitive suppliers that do not have ease of use built in from the ground up as we do.  Although the customer from the banking sector has a long-standing relationship at head office level with a major competitor, our engagement model and the simplicity of implementation convinced them to select Osirium. We planned and executed a well-defined Proof of Concept over 3 weeks, with the solution up and running within the first 24 hours, and able to meet their exact requirements. This focus on customers and our ability to rapidly deliver real value and security is one of the factors driving our success."

 

–      Ends –

For further information:

Osirium Technologies plc	Tel: +44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7710 7600
Fred Walsh / Neil Shah
Alma PR	Tel +44 (0) 20 3405 0205

Josh Royston, Hilary Buchanan, Kieran Breheny

 

Notes to Editors:

 

About Osirium

 

Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation PAM solution.  The team has developed the concept of a Virtual Air Gap to separate users from passwords.  Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAMMMGGVLFGLZM

Close

×

RNS Number : 3653P

Immotion Group PLC

10 October 2019

 

 

 

Immotion Group plc

("Immotion Group" or the "Company")

 

 Immotion signs deal with Aspro Parks for Blue Planet Aquarium Cheshire

Immotion Group, the UK-based immersive virtual reality ("VR") 'Out of Home' entertainment group, is pleased to announce a partnership with major Spanish leisure operator Aspro Parks to place a VR Cinema Pod in the Blue Planet Aquarium, Cheshire as the first site in a potential roll-out of Immotion VR installations.

Aspro Parks is one of the largest European operators of leisure parks and centres with 68 locations across 10 countries including the UK, Spain, France and Germany. Their parks range from aquariums such as Blue Planet to Zoological and Marine Parks, Water Parks and Family Attraction Parks.

 

Beyond the Blue Planet Aquarium installation, and dependent on its success, we are in talks for an installation in the Aspro-operated Bristol Aquarium with a further roll-out to other Aspro operated aquariums with the 'edutainment' slate of content, and leisure centres with Immotion's pure entertainment content, both Cinema Pod-related and multiplayer interactive experiences.

 

Joining the Blue Planet Aquarium in signing deals this week are SeaLife, Paris, and Point Defiance, Tacoma, Washington, USA.

 

Including these new partnerships, the Company has added six new aquarium partner sites (18 new headsets in total) in recent weeks and has in excess of ten more sites in varying stages of completion following its very successful tour of the American and European Zoo and Aquarium shows in New Orleans and Valencia respectively.

 

Rod Findley, Immotion Group Commercial Director said: "I am very excited to be partnering with Aspro Parks for the Blue Planet Aquarium in Cheshire. They are an excellent brand and we feel that this will be a great starting place for a long and fruitful partnership. In many ways, Aspro is the perfect match for us in that they not only want the educational content for aquariums, but also can take advantage of the pure entertainment offerings like our multiplayer experiences and our bespoke roller coaster experiences in their other leisure sites. We are very confident that the ancillary revenue they will generate combined with the positive guest reaction, will prove a huge success for Aspro and for Immotion.  Our relationships with multinational leisure operators like Aspro and Merlin are an important cornerstone for our business and should provide a great opportunity for growth along with the addition of independent aquariums, zoos, museums and science centres worldwide.

 

 

 

Enquiries:

 For further information please visit www.immotion.co.uk, or contact: 

 

Immotion Group	Martin Higginson	Tel: +44 (0) 161 235 8505
WH Ireland Limited (Nomad and Joint Broker)	Adrian Hadden  Darshan Patel	Tel + 44 (0) 207 220 1666
Shard Capital Partners LLP (Joint Broker)	Damon Heath Erik Woolgar	Tel: +44 (0) 20 7186 9900
Alvarium Capital Partners	Alex Davies	Tel: +44 (0) 207 195 1433

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRALLFSTIELAIIA

Close

×

RNS Number : 2102P

Pressure Technologies PLC

09 October 2019

 

 

 

 

 

 

9 October 2019

 

Pressure Technologies plc

("Pressure Technologies" or the "Group")

 

 

Major Contract Win with EDF Energy for Nitrogen Storage Solutions at UK Nuclear Power Plants

 

Pressure Technologies (AIM: PRES), the specialist engineering group, is pleased to announce that its wholly owned subsidiary, Sheffield based Chesterfield Special Cylinders Limited (CSC), has secured a significant contract in excess of £3 million to supply nitrogen storage solutions to EDF Energy for its UK nuclear power plants at Heysham, Torness and Hartlepool.

 

This design and supply contract comprises ultra large high pressure cylinders manufactured at CSC's Sheffield facility, in an innovative series of nitrogen storage packages to meet EDF Energy's operational requirements.  The modular design is seismically qualified to allow ease of installation at EDF Energy's sites. The cylinder packages will be supplied to EDF Energy by mid-2020.

 

Chris Walters, Chief Executive Officer of Pressure Technologies, commented:

 

"This contract represents the largest order in Chesterfield Special Cylinders' history outside of the defence sector and is extremely important for the Chesterfield team and for the Pressure Technologies Group. Through the provision of these safety-critical systems, we are delighted to be supporting EDF Energy's existing and continued commitment to supply safe, low-carbon electricity to UK homes."

 

CSC is a long-standing key supplier of gas storage solutions to power stations across the UK.

 

 

For further information, please contact:

 

Pressure Technologies plc
Chris Walters, Chief Executive	Tel: 0114 257 3616
Joanna Allen, Chief Financial Officer	[email protected]
N+1 Singer (Nomad and Broker)	Tel: 0207 496 3000
Mark Taylor / Lauren Kettle
IFC Advisory Ltd (Financial PR and IR)	Tel: 0203 934 6630
Graham Herring / Tim Metcalfe / Zach Cohen

 

 

 

COMPANY DESCRIPTION

 

Company description – www.pressuretechnologies.com

With its head office in Sheffield, the Pressure Technologies Group was founded on its leading market position as a designer and manufacturer of high-integrity, safety-critical components and systems serving global supply chains in oil and gas, defence, industrial gases and hydrogen energy markets.

 

The Group has two divisions, Precision Machined Components and Chesterfield Special Cylinders.

 

Precision Machined Components (PMC) – www.pt-pmc.com

●    Precision Machined Components includes the Al-Met, Roota Engineering, Quadscot and Martract brands.

 

Chesterfield Special Cylinders (CSC) – www.chesterfieldcylinders.com 

●    Chesterfield Special Cylinders, Sheffield, includes CSC Deutschland Gmbh, which is based in Dorsten, Germany and Chesterfield Special Cylinders Inc. which is based in Houston, USA

 

……………………………………………………………………………………………………….

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTDBBDGCXGBGCI

Close

×

RNS Number : 2217O

Crimson Tide PLC

01 October 2019

 

1st October 2019

Crimson Tide PLC

("Crimson Tide" or "the Company")

Significant long-term contract win with leading supermarket

 

Crimson Tide (TIDE) announces that it has entered into a significant contract for its mpro5 solution with one of the country's leading retailers. The contracted revenue is for a minimum of £1.4m over the 36-month term. The mpro5 platform will now be used in nearly 4,000 retail locations across the UK and Ireland alone, with international expansion potential. A previous, smaller contract with the client containing hardware had reached its term and is now included on a SaaS only basis within this new contract.

The mpro5 solution has been successfully used over the last 3 years for the purposes of store cleanliness and safety within 400 stores in the UK. Due to the configurable nature of the mpro5 platform, the client has been able to replace a number of internal systems from competitors and consolidate their requirements for Store Cleaning, Security, Catering, Distribution, Food Safety, and Safe & Legal compliance into the single mpro5 offering. An early trial of mpro5 with IOT sensors is currently under way and could add significantly to the revenues achievable with the client in the future.

Barrie Whipp, Executive Chairman commented "Our team has worked tirelessly over the contract term to demonstrate the unique nature of the mpro5 platform. Having gained visibility at C-level with this retailer, we are excited by the international potential for this client in future years. This contract is indicative of our enterprise-class pipeline that we have invested in strategically, and I am pleased that our unrivalled platform capability has given this client a significant return on investment with mpro5."

 

Enquiries:

Crimson Tide plc                                           01892 542444 

Barrie Whipp / Luke Jeffrey

Arden Partners                                              020 7614 5900

John Llewellyn-Lloyd / Dan Gee-Summons

 

For further information on Crimson Tide plc, see the website at: www.crimsontide.co.uk

The information contained within this RNS is considered to be inside information prior to its release.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected]om or visit www.rns.com.

 

END

 

 

CNTURVVRKVAKOAR

Close

×

RNS Number : 0227O

Solid State PLC

30 September 2019

 

 

Solid State plc

("Solid State", the "Company" or the "Group")

$3m US Rail Infrastructure Contract

 

 

Solid State plc (AIM: SOLI), the AIM listed manufacturer of computing, power and communications products, and value added distributor of electronic components, is pleased to announce an international contract win.

 

The contract, valued at $3m, has been won by the Group's Pacer Optoelectronics business unit, acquired by Solid State in November 2018. The display project, a rail infrastructure programme in the United States, will utilise Pacer's value added capabilities and is expected to be delivered over the next nine months.

 

Commenting on the contract Gary Marsh, Chief Executive of Solid State, said:

 

"This contract is a good example of the success of our acquisition strategy in broadening our international and sector reach.  We have focussed on niche sectors where we can apply our value added engineering capability and where we can sell into increasingly international markets.  The transportation sector has been a specific target and therefore this success is particularly pleasing."

 

For further information please contact:

 

Solid State plc	01527 830 630
Gary Marsh – Chief Executive Peter James – Group Finance Director	[email protected]
Walbrook PR (Financial PR)	020 7933 8780
Tom Cooper / Paul Vann	0797 122 1972
	[email protected]

 

 

 

Notes to Editors:

 

Solid State plc (SOLI) is a value added electronics group supplying industrial and military markets with ruggedised/durable components, assemblies and manufactured units for use in harsh environments.  The Group's mantra is – 'Trusted technology for demanding applications'.

 

Operating through two main divisions: Manufacturing (Steatite) and Value Added Distribution (Solid State Supplies & Pacer); the Group specialises in complex engineering challenges often requiring design-in support and component sourcing for computing, power, communications, electronic and optoelectronic products.

 

Headquartered in Redditch, Solid State employs over 200 staff across the UK with a branch office in the USA, serving niche markets in oil & gas production, transportation, medical, construction, security, military and field maintenance. 

 

Solid State was established in 1971 and admitted to AIM in June 1996.  The Group has grown organically and by acquisition – having made 10 acquisitions.    

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRALRMATMBJTBJL

Close

×

RNS Number : 5426N

Immotion Group PLC

25 September 2019

 

 

 

Immotion Group plc

("Immotion Group", "Immotion", the "Company")

 Partnership update

 

Immotion Group, the UK-based immersive 'Out of Home' entertainment group, is pleased to announce agreements for three further installs in its fast growing Aquarium sector.

 

The first of which is with Dubai Aquarium, sited in the largest shopping mall in the World, the Dubai Mall, which boasts over 80 million visitors per annum. Immotion will install an initial four headsets in the Dubai Mall just outside the entrance of the Dubai Aquarium, one of the largest suspended aquariums in the World with over 140 species, including the largest collection of Sand Tiger Sharks in the World.

 

The two additional installs, four headsets each, are in Texas; the first at San Antonio Aquarium, and the second Austin's Aquarium.

 

These new additions will all feature the 'Ocean Explorer' series of experiences, including the latest experience from Immotion; 'Shark Dive' – a live action VR experience where users can get up close with Tiger and Hammerhead Sharks.

 

As noted in our interim statement, we are seeing excellent performance from the aquarium sector, which is currently trading ahead of our overall partner revenues, which in turn are trading ahead of our overall headsets revenues.

 

Martin Higginson, Immotion Group CEO said: "Demand from the aquarium market is really starting to gain traction. We now have over 50 active leads from this sector which gives us real confidence in hitting our EBITDA breakeven figures in Q1 2020. Signing up Dubai Aquarium is another major milestone in the Company's growth story. Not only is this one of the largest aquariums, it is located in the largest shopping mall in the World with over 80 million visitors a year."

 

Enquiries:

 For further information please visit www.immotion.co.uk, or contact: 

 

Immotion Group	Martin Higginson	Tel: +44 (0) 161 235 8505
WH Ireland Limited (Nomad and Joint Broker)	Adrian Hadden  Darshan Patel Matthew Chan	Tel + 44 (0) 207 220 1666
Shard Capital Partners LLP (Joint Broker)	Damon Heath Erik Woolgar	Tel: +44 (0) 20 7186 9900
Alvarium Capital Partners	Alex Davies	Tel: +44 (0) 207 195 1433

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRADGGDCDUDBGCS

Close